These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19846783)

  • 1. Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue.
    Song H; Yoon C; Kattman SJ; Dengler J; Massé S; Thavaratnam T; Gewarges M; Nanthakumar K; Rubart M; Keller GM; Radisic M; Zandstra PW
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3329-34. PubMed ID: 19846783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered heart tissue enables study of residual undifferentiated embryonic stem cell activity in a cardiac environment.
    Dengler J; Song H; Thavandiran N; Massé S; Wood GA; Nanthakumar K; Zandstra PW; Radisic M
    Biotechnol Bioeng; 2011 Mar; 108(3):704-19. PubMed ID: 21246514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes.
    Qiao H; Zhang H; Yamanaka S; Patel VV; Petrenko NB; Huang B; Muenz LR; Ferrari VA; Boheler KR; Zhou R
    Circ Cardiovasc Imaging; 2011 Jan; 4(1):33-41. PubMed ID: 21059858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function.
    Liau B; Christoforou N; Leong KW; Bursac N
    Biomaterials; 2011 Dec; 32(35):9180-7. PubMed ID: 21906802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblasts support functional integration of purified embryonic stem cell-derived cardiomyocytes into avital myocardial tissue.
    Xi J; Khalil M; Spitkovsky D; Hannes T; Pfannkuche K; Bloch W; Sarić T; Brockmeier K; Hescheler J; Pillekamp F
    Stem Cells Dev; 2011 May; 20(5):821-30. PubMed ID: 21142494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization.
    Masumoto H; Matsuo T; Yamamizu K; Uosaki H; Narazaki G; Katayama S; Marui A; Shimizu T; Ikeda T; Okano T; Sakata R; Yamashita JK
    Stem Cells; 2012 Jun; 30(6):1196-205. PubMed ID: 22438013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimentally-guided in silico design of engineered heart tissues to improve cardiac electrical function after myocardial infarction.
    Rosales RM; Mountris KA; Oliván-Viguera A; Pérez-Zabalza M; Cedillo-Servin G; Iglesias-García O; Hrynevich A; Castilho M; Malda J; Prósper F; Doblaré M; Mazo MM; Pueyo E
    Comput Biol Med; 2024 Mar; 171():108044. PubMed ID: 38335818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.
    Riegler J; Tiburcy M; Ebert A; Tzatzalos E; Raaz U; Abilez OJ; Shen Q; Kooreman NG; Neofytou E; Chen VC; Wang M; Meyer T; Tsao PS; Connolly AJ; Couture LA; Gold JD; Zimmermann WH; Wu JC
    Circ Res; 2015 Sep; 117(8):720-30. PubMed ID: 26291556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts.
    Gerbin KA; Yang X; Murry CE; Coulombe KL
    PLoS One; 2015; 10(7):e0131446. PubMed ID: 26161513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
    Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
    Higuchi T; Miyagawa S; Pearson JT; Fukushima S; Saito A; Tsuchimochi H; Sonobe T; Fujii Y; Yagi N; Astolfo A; Shirai M; Sawa Y
    Cell Transplant; 2015; 24(12):2479-89. PubMed ID: 25606821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers.
    Xue T; Cho HC; Akar FG; Tsang SY; Jones SP; Marbán E; Tomaselli GF; Li RA
    Circulation; 2005 Jan; 111(1):11-20. PubMed ID: 15611367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility.
    Pfannkuche K; Liang H; Hannes T; Xi J; Fatima A; Nguemo F; Matzkies M; Wernig M; Jaenisch R; Pillekamp F; Halbach M; Schunkert H; Sarić T; Hescheler J; Reppel M
    Cell Physiol Biochem; 2009; 24(1-2):73-86. PubMed ID: 19590195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laminin-221 Enhances Therapeutic Effects of Human-Induced Pluripotent Stem Cell-Derived 3-Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy Model.
    Samura T; Miyagawa S; Kawamura T; Fukushima S; Yokoyama JY; Takeda M; Harada A; Ohashi F; Sato-Nishiuchi R; Toyofuku T; Toda K; Sekiguchi K; Sawa Y
    J Am Heart Assoc; 2020 Aug; 9(16):e015841. PubMed ID: 32783519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
    Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell Transcriptomics of Engineered Cardiac Tissues From Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome.
    Lam YY; Keung W; Chan CH; Geng L; Wong N; Brenière-Letuffe D; Li RA; Cheung YF
    J Am Heart Assoc; 2020 Oct; 9(20):e016528. PubMed ID: 33059525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro platform of allogeneic stem cell-derived cardiomyocyte transplantation for cardiac conduction defects.
    Yoshida A; Lee JK; Tomoyama S; Miwa K; Shirakawa K; Hamanaka S; Yamaguchi T; Nakauchi H; Miyagawa S; Sawa Y; Komuro I; Sakata Y
    Europace; 2018 Sep; 20(9):1553-1560. PubMed ID: 29554331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.